Fujifilm Diosynth commences cell culture expansion project

The investment to take on this project was announced in June 2020

picture of

Breaking News

Lonza to double drug substance production for Moderna vaccine

In May 2020, the companies announced a 10-year agreement to enable the manufacture of the COVID-19 vaccine and ...

Asher contracts ProBioGen to develop lead candidate

ProBioGen will now advance the development of Asher's lead candidate in immuno-oncology, applying its transposase ...

AavantiBio and Catalent announce partnership

Catalent will support the development and manufacturing of AavantiBio’s gene therapies for rare genetic diseases

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part III)

Dr Kevin Robinson held a virtual roundtable with representatives from a number of top-tier contract (development and) ...

DNA Script Partners with Moderna

The partnership will develop a prototype for the on-demand manufacturing of caccines and therapeutics for DARPA

Evonik delivers first lipids from German facility to BioNTech

The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle

Taking a lifecycle approach to fill-finish success

Dr Kevin Robinson recently spoke to swissfillon founder and CEO, Daniel Kehl, and Business Development Director, Carole ...

Siemens offers ‘resilience-as-a-service’ for manufacturers

The service encompasses risk identification, risk management and issue resolution

GEA equips Biopharma plant in Ukraine with separator technology

Three specialised GEA chamber separators for blood plasma fractionation, including the BKI 45, have been installed in ...

The CMO RFQ process and expectation management

Managing expectations during a request for quotation (RFQ) process is a crucial part of establishing a trustful and ...

Harnessing the power of HPAPIs: key considerations

Adam Kujath, Senior Director at Sterling Pharma Solutions, discusses the key issues that companies need to consider ...

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part II)

Dr Kevin Robinson held a virtual roundtable with representatives from a number of top-tier contract (development and) ...

ABEC CSR single-use fermenters to support Catalent expansion

Catalent is applying ABEC’s technology to expand its plasmid DNA manufacturing capabilities

Moderna and Catalent announce expanded vaccine collaboration

In September 2020, Catalent announced a $50 m investment into the third high-speed vial filling line at Bloomington. ...